Recruiting Pulmonary Fibrosis Studies in Los Angeles
About Pulmonary Fibrosis Clinical Trials in Los Angeles
Pulmonary fibrosis is a condition in which the lung tissue becomes damaged and scarred, making it difficult for the lungs to function properly. Idiopathic pulmonary fibrosis (IPF) is the most common form with unknown cause. Antifibrotic medications can slow progression, and lung transplant may be considered.
There are currently 14 pulmonary fibrosis clinical trials recruiting participants in Los Angeles, CA. These studies are seeking a combined 7,631 participants. Research is being sponsored by Duke University, Boehringer Ingelheim, United Therapeutics and 8 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Pulmonary Fibrosis Clinical Trials in Los Angeles — FAQ
Are there pulmonary fibrosis clinical trials in Los Angeles?
Yes, there are 14 pulmonary fibrosis clinical trials currently recruiting in Los Angeles, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Los Angeles?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Los Angeles research site will contact you about next steps.
Are clinical trials in Los Angeles free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Los Angeles studies also compensate for your time and travel.
What pulmonary fibrosis treatments are being tested?
The 14 active trials in Los Angeles are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary fibrosis.
Data updated July 18, 2026 from ClinicalTrials.gov